| Literature DB >> 22459544 |
Kiyotaka Fukamachi1, Akira Shiose, Alex L Massiello, David J Horvath, Leonard A R Golding, Sangjin Lee, Randall C Starling.
Abstract
Although the need for right ventricular assist device (RVAD) support for right ventricular failure after the implantation of a continuous-flow left ventricular assist device has decreased, right ventricular failure still occurs in as many as 44% of patients after continuous-flow left ventricular assist device insertion. Cleveland Clinic's DexAide continuous-flow RVAD was implanted in 34 calves during the course of its development. This review discusses lessons learned in the design and development of an implantable continuous-flow RVAD that are drawn from the results of these in vivo studies, our clinical experience with RVAD support, and a review of previously published reports on clinical RVAD use.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22459544 PMCID: PMC3447008 DOI: 10.1016/j.athoracsur.2012.02.026
Source DB: PubMed Journal: Ann Thorac Surg ISSN: 0003-4975 Impact factor: 4.330